The Ipsos survey of 1,078 adults found 24 of people would use weight-loss jabs if they were provided for free by the health service.

Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

The ads promise GLP-1 medications for diabetes and weight loss delivered to your door at prices that can’t be beaten. It ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Chances are you have family or friends who have struggled with weight loss for years, losing weight on the latest fad just to gain it all back again and more. Today it is happening again with GLP1 ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...